These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24337593)

  • 61. Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus.
    Sobhy A; Fakhry M M; A Azeem H; Ashmawy AM; Omar Khalifa H
    J Investig Med; 2019 Mar; 67(3):681-685. PubMed ID: 30385593
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mean Platelet Volume/Platelet Count Ratio as a Predictor of 3-Month Mortality in HBV-Related Decompensated Cirrhosis Patients.
    Ding QM; Zhou WQ; Mao WL; Zhang JF
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162863
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis.
    McGoogan KE; Smith PB; Choi SS; Berman W; Jhaveri R
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):344-6. PubMed ID: 20118806
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of Sleeve Gastrectomy on Platelet Counts and Mean Platelet Volumes.
    Kutluturk F; Ozsoy Z
    Obes Surg; 2018 Oct; 28(10):3159-3164. PubMed ID: 29717406
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Noninvasive markers to diagnose cirrhosis in patients with HBeAg positive chronic hepatitis: Do new biomarkers improve the accuracy?
    Park SH; Kim DJ; Cheong JY; Cho SW; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB
    Clin Biochem; 2010 Jul; 43(10-11):877-81. PubMed ID: 20433821
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potential circulating biomarkers of circulating chemokines CCL5, MIP-1β and HA as for early detection of cirrhosis related to chronic HBV (hepatitis B virus) infection.
    Hu L; Zhu Y; Zhang J; Chen W; Li Z; Li L; Zhang L; Cao D
    BMC Infect Dis; 2019 Jun; 19(1):523. PubMed ID: 31200663
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients.
    Coskun BD; Altinkaya E; Sevinc E; Ozen M; Karaman H; Karaman A; Poyrazoglu O
    Rev Esp Enferm Dig; 2015 Dec; 107(12):740-4. PubMed ID: 26671586
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.
    Wang J; Chen Z; Yan X; Yang Y; Liu Y; Chen Y; Jia B; Xia J; Xiong Y; Zhang Z; Ding W; Huang R; Wu C
    Discov Med; 2019 Sep; 28(153):149-158. PubMed ID: 31926586
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of Both Protein C and Antithrombin III as Predictors of Stage of Liver Disease in Chronic Viral Hepatitis B or C Infected Patients.
    Abo-Elenein AM; Mabrouk MM; Abou-Saif S; Saeed OM; Khodeir S; Elkadeem M; Elashry H; Haydara T; Zaghloul MS; Seleem WM; Elshweikh SA; Abd-Elsalam S
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):112-117. PubMed ID: 31142255
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers.
    Liang XE; Zhong C; Huang L; Yang S; Zhu Y; Chen Y; Hou J
    J Gastroenterol Hepatol; 2017 Feb; 32(2):459-465. PubMed ID: 27346683
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus.
    Ikarashi Y; Kodama K; Taniai M; Hashimoto E; Tokushige K
    Intern Med; 2018 Apr; 57(8):1065-1070. PubMed ID: 29269684
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B.
    Venkatesh SK; Wang G; Lim SG; Wee A
    Eur Radiol; 2014 Jan; 24(1):70-8. PubMed ID: 23928932
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
    Chen Y; Wang Y; Chen Y; Yu Z; Chi X; Hu KQ; Li Q; Tan L; Xiang D; Shang Q; Lei C; Chen L; Hu X; Wang J; Liu H; Lu W; Chi W; Dong Z; Wang X; Li Z; Xiao H; Chen D; Bai W; Zhang C; Xiao G; Qi X; Chen J; Zhou L; Sun H; Deng M; Qi X; Zhang Z; Qi X; Yang Y
    Clin Transl Gastroenterol; 2019 May; 10(5):1-12. PubMed ID: 31033506
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An MLP classifier for prediction of HBV-induced liver cirrhosis using routinely available clinical parameters.
    Cao Y; Hu ZD; Liu XF; Deng AM; Hu CJ
    Dis Markers; 2013; 35(6):653-60. PubMed ID: 24302810
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between serum platelet-derived growth factor BB and degree of liver damage, fibrosis and hepatitis B e antigen (HBeAg) status in CHB patients.
    Diang XC; Ma LN; Li YF; Liu XY; Zhang X; Liu JY; Sheng YJ; Zhang DZ; Hu HD; Ren H
    Hepatogastroenterology; 2012; 59(120):2357-60. PubMed ID: 22688015
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
    Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
    World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PLATELET INDICES AND LIVER FIBROSIS EVALUATION IN CHRONIC HEPATITIS C.
    Gîrleanu I; Trifan A; Sîngeap AM; Stoica OC; Cojocariu C; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):55-61. PubMed ID: 27125073
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High Mean Platelet Volume Is Associated with Worse Outcomes in Patients with HBV-Related Decompensated Cirrhosis.
    Ma Y; Quan W; Zhu H
    Ann Clin Lab Sci; 2018 Sep; 48(5):639-645. PubMed ID: 30373870
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis.
    Chrysanthos NV; Papatheodoridis GV; Savvas S; Kafiri G; Petraki K; Manesis EK; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):389-96. PubMed ID: 16538110
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis.
    Jin BX; Zhang YH; Jin WJ; Sun XY; Qiao GF; Wei YY; Sun LB; Zhang WH; Li N
    Sci Rep; 2015 Oct; 5():15026. PubMed ID: 26456479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.